CISPLATIN INDUCED EMESIS - PRELIMINARY-RESULTS INDICATIVE OF CHANGES IN PLASMA-LEVELS OF 5-HYDROXYTRYPTAMINE

被引:42
作者
BARNES, NM
GE, J
JONES, WG
NAYLOR, RJ
RUDD, JA
机构
[1] UNIV LEEDS,COOKRIDGE HOSP,DEPT RADIOTHERAPY,CTR REG RADIOTHERAPY,TUNBRIDGE BLDG,LEEDS LS16 6QB,W YORKSHIRE,ENGLAND
[2] UNIV BRADFORD,SCH PHARM,POSTGRAD STUDIES PHARMACOL,BRADFORD BD7 1DP,ENGLAND
关键词
D O I
10.1038/bjc.1990.395
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:862 / 864
页数:3
相关论文
共 15 条
[1]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[2]  
CARMICHAEL J, 1989, CANCER CHEMOTH PHARM, V24, P45
[3]   5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM TO PREVENT CISPLATIN-INDUCED EMESIS [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TATTERSALL, FD .
NEUROPHARMACOLOGY, 1986, 25 (08) :959-961
[4]   EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING [J].
CUBEDDU, LX ;
HOFFMANN, IS ;
FUENMAYOR, NT ;
FINN, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :810-816
[5]   PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST [J].
CUNNINGHAM, D ;
POPLE, A ;
FORD, HT ;
HAWTHORN, J ;
GAZET, JC ;
CHALLONER, T ;
COOMBES, RC .
LANCET, 1987, 1 (8548) :1461-1463
[6]   SERUM PROSTAGLANDIN-F2-ALPHA CONCENTRATION IN CARCINOID-SYNDROME [J].
FELDMAN, JM ;
PLONK, JW ;
CORNETTE, JC .
PROSTAGLANDINS, 1974, 7 (06) :501-506
[7]   THE ROLE OF THE ABDOMINAL VISCERAL INNERVATION AND 5-HYDROXYTRYPTAMINE M-RECEPTORS IN VOMITING INDUCED BY THE CYTO-TOXIC DRUGS CYCLOPHOSPHAMIDE AND CISPLATIN IN THE FERRET [J].
HAWTHORN, J ;
OSTLER, KJ ;
ANDREWS, PLR .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1988, 73 (01) :7-21
[8]   5-HT3 RECEPTOR ANTAGONISTS INJECTED INTO THE AREA POSTREMA INHIBIT CISPLATIN-INDUCED EMESIS IN THE FERRET [J].
HIGGINS, GA ;
KILPATRICK, GJ ;
BUNCE, KT ;
JONES, BJ ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (01) :247-255
[9]   PHASE-II TRIALS OF THE SEROTONIN ANTAGONIST GR38032F FOR THE CONTROL OF VOMITING CAUSED BY CISPLATIN [J].
KRIS, MG ;
GRALLA, RJ ;
CLARK, RA ;
TYSON, LB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (01) :42-46
[10]  
LEIBUNDGUT U, 1987, LANCET, V1, P1198